Page 60 - Read Online

Sazonova et al. Vessel Plus 2019;3:5 I http://dx.doi.org/10.20517/2574-1209.2018.56 Page 9 of 9

subendocardial dysfunction in mitochondrial DNA point mutation carriers. Eur Heart J Cardiovasc Imaging 2013;14:650-8.
24. Sazonova M, Budnikov E, Khasanova Z, Sobenin I, Postnov A, et al. Studies of the human aortic intima by a direct quantitative assay of
mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204:184-90.
25. Sazonova MA, Ryzhkova AI, Sinyov VV, Galitsyna EV, Orekhova VA, et al. New markers of atherosclerosis: a threshold level of
heteroplasmy in mtDNA mutations. Vessel Plus 2017;1:182-91.
26. Sazonova MA, Postnov AIu, Orekhov AN, Sobenin IA. A new method of quantitative estimation of mutant allele in mitochondrial
genome. Patol Fiziol Eksp Ter 2011;4:81-4.
27. Sobenin IA, Mitrofanov KY, Zhelankin AV, Sazonova MA, Postnov AY, et al. Quantitative assessment of heteroplasmy of mitochondrial
genome: perspectives in diagnostics and methodological pitfalls. Biomed Res Int 2014;2014:292017.
28. Sazonova MA Association of mitochondrial genome mutations with lipofibrous plaques in human aortic intima. Patol Fiziol Eksp Ter
2015;59:17-28.
29. Sazonova MA, Sinyov VV, Ryzhkova AI, Galitsyna EV, Khasanova ZB, et al. Role of mitochondrial genome mutations in pathogenesis
of carotid atherosclerosis. Oxidative Medicine and Cellular Longevity 2017;2017:1-7.
30. Sazonova MA, Sinyov VV, Barinova VA, Ryzhkova AI, Zhelankin AV, et al. Mosaicism of mitochondrial genetic variation in
atherosclerotic lesions of the human aorta. Biomed Res Int 2015;2015:825468.
31. Ryzhkova A, Sazonova M, Sinyov V, Galitsyna E, Barinova V, et al. Detection of threshold heteroplasmy level of mtDNA in lypofibrous
plaques of human aortic intima. Atherosclerosis 2016;252:e80.
32. Sazonova, MA, Amosenko, FA, Kapranov NI, Kalinin VN. Molecular genetic analysis of TUB18 and TUB20 intragenic polymorphism
and various mutations of the CFTR gene in the Moscow region. Genetika 1997;33:1303-7. (in Russian)
33. Amosenko FA, Sazonova MA, Kapranov NI, Trubnikova IS, Kalinin VN. Analysis of various polymorphic markers of the CFTR gene
in cystic fibrosis patients and healthy donors from the Moscow region. Russ J Genet 1995;31:457-9.
34. Amosenko FA, Trubnikova IS, Zakhar’ev VM, Bannikov VM, Sazonova, MA, et al. TUB9 polymorphism in the CFTR gene of cystic
fibrosis patients, carriers, and healthy donors from the Moscow region. SSCP and restriction analyses. Genetika 1997;33:257-61. (in
Russian)
35. Alderborn A, Kristofferson A, Hammerling U. Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA
sequencing. Genome Res 2000;10:1249-58.
36. Simou M, Kouskouni E, Vitoratos N, Economou E, Creatsas G. Polymorphisms of platelet glycoprotein receptors and cell adhesion
molecules in fetuses with fetal growth restriction and their mothers as detected with pyrosequencing. In Vivo 2017;31:243-9.
37. Pu D, Pan R, Liu W, Xiao P. Quantitative analysis of single-nucleotide polymorphisms by pyrosequencing with di-base addition.
Electrophoresis 2017;38:876-85.
38. Sazonova MA, Budnikov YY, Khazanova ZB, Postnov AY, Sobenin IA, et al. Direct quantitative assessment of mutant allele in
mitochondrial genome in atherosclerotic lesion of human aorta. Atherosclerosis Suppl 2007;8:45-6.
39. Sazonova M, Andrianova I, Khasanova Z, Sobenin I, Postnov A. Quantitative mitochondrial genome mutation investigation and
possible role of the somatic mutations in development of atherosclerotic lesion of human aorta. Atherosclerosis Suppl 2008;9:113.
40. IBM SPSS software. Available from: https://www.ibm.com/analytics/us/en/technology/spss. [Last accessed on 21 Feb 2019]